Please login to the form below

Not currently logged in
Email:
Password:

Access to Medicines Index

This page shows the latest Access to Medicines Index news and features for those working in and with pharma, biotech and healthcare.

GSK tops Access to Medicines Index for fifth time running

GSK tops Access to Medicines Index for fifth time running

GSK tops Access to Medicines Index for fifth time running. Leads J&J and Novartis in 'needs-orientation' while Roche and Astellas lag. ... The Access to Medicines Index 2016. View the Access to Medicines Index 2016.

Latest news

  • GSK unveils access plan for low-income countries GSK unveils access plan for low-income countries

    The company's chief executive Sir Andrew Witty - who will step down next year - announced the measure just ahead of the UN High Level Panel on Access to Medicines yesterday. ... GSK already has a good track record on medicines access, ranking at number

  • Novartis to make 15 drugs available at $1 a month Novartis to make 15 drugs available at $1 a month

    Novartis has launched an access programme aimed at low-and middle-income countries that will make 15 of its medicines for chronic diseases available at a knockdown price. ... Novartis was ranked fourth in the 2014 Access to Medicines Index funded by the

  • GSK tops pharma access to medicines table GSK tops pharma access to medicines table

    The biannual Access To Medicines Index (ATMI) - which is funded by the Bill &Melinda Gates Foundation and the UK and Dutch governments - puts GlaxoSmithKline at the top of its rankings in ... The Access to Medicines Index 2014. "In recent years,

  • Archive listing

    GSK tops Access to Medicines Index for fifth time running. ... Warns of deprioritised status if negotiators fail to secure access to the single market. .

  • EU pharma heading efforts to get drugs to the poor

    efforts to increase the level of access to affordable medicines for the poor. ... The Access to Medicines Index was launched on June 16 and shows that only one US manufacturer, Merck &Co, which came third, has made it into the top seven.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics